Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Alignment Healthcare, Inc.'s SEC filings document a Medicare Advantage operating company with common stock listed on Nasdaq under ALHC. Its Form 8-K reports furnish quarterly and annual operating results, health plan membership, revenue, adjusted gross profit, adjusted EBITDA, guidance updates and Regulation FD materials related to strategy, market position and Medicare Advantage quality ratings.
Proxy materials cover board elections, executive compensation, equity awards, pay-versus-performance data and shareholder voting matters. Registration statements, prospectus supplements and underwriting agreements describe secondary offerings of common stock by selling stockholders, the company's capital structure and related securities-law obligations.
ALHC filed a Form 144 notice indicating proposed sales of Common stock consisting of 35,951 shares tied to restricted stock units granted 03/13/2026. The filing lists a prior sale by Hyong J Kim of 18,404 shares on 03/18/2026 for $328,327.36.
The filing is a regulatory notice of intended resale by an issuer/holder under applicable resale rules; timing and distribution mechanics are included in the filing headings.
Morgan Stanley Smith Barney LLC reports a Form 144 filing indicating securities sold by Sebastian Burzacchi. The filing lists a sale of 15,361 common shares on 03/18/2026 for $274,040.24. It also shows 1,142 Restricted Stock Units dated 03/13/2026 and the filing appears on 06/12/2026.
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, reported an open-market sale of company stock. On June 11, 2026, he sold 25,000 shares of Common Stock at $21.00 per share in a non-derivative transaction.
After this sale, he directly holds 1,178,816 shares of Alignment Healthcare common stock. The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on March 4, 2026, indicating it was scheduled in advance rather than timed opportunistically.
Alignment Healthcare, Inc. director and Chief Executive Officer John E. Kao reported indirect open-market sales of company common stock made through the JEK Trust, of which he is trustee. On June 10, 2026, the trust sold 223,064 shares at a weighted-average price of $20.5962 per share and 74,936 shares at a weighted-average price of $19.6481 per share, under a Rule 10b5-1 trading plan adopted on November 21, 2025. Following these transactions, the JEK Trust held 1,609,830 shares indirectly, while Mr. Kao’s direct holdings were 1,608,743 shares, after a transfer of 176,125 shares from direct ownership to the trust.
Alignment Healthcare, Inc. reported the results of its virtual annual stockholder meeting held on June 4, 2026. Stockholders representing 194,112,992 shares of common stock were present or represented by proxy.
All three Class II director nominees — Jody Bilney, David Hodgson, and Jacqueline Kosecoff — were elected to three-year terms ending at the 2029 annual meeting. Stockholders also ratified the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. In addition, on an advisory basis, stockholders approved the compensation of the company’s named executive officers in the say-on-pay vote.
Kent Mark D. reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare, Inc. reported that President - MSO Mark D. Kent received a grant of 87,719 restricted stock units of Common Stock. These units vest in roughly equal one-third installments on March 13, 2027, 2028 and 2029, contingent on continued service, bringing his direct holdings to 102,567 shares.
KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.
Alignment Healthcare EVP Corporate Affairs Joseph S. Konowiecki received a grant of 122,807 restricted stock units of common stock. The award was made at no cash cost to him and is compensation-related rather than an open‑market purchase.
Each restricted stock unit represents one share of Alignment Healthcare common stock. The units will vest in three roughly equal installments on March 13, 2027, March 13, 2028 and March 13, 2029, as long as he continues serving the company on those dates. After this grant, he directly holds 1,203,816 shares of common stock.
Alignment Healthcare, Inc. President - MSO Mark D. Kent reported an open-market purchase of 14,848 shares of Common Stock at $13.31 per share on June 2, 2026. Following this transaction, he directly holds 14,848 shares.
Alignment Healthcare, Inc. filed an initial Form 3 for Shane J. Hochradel, who serves as Chief Operations Officer. This filing establishes him as a reporting person for Alignment Healthcare equity. The submission reports no insider transactions or holdings details in the disclosed data.